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TAK1Stringent negative regulation of the transcription factor NF-κB is essential for maintaining cellular stress re-
sponses and homeostasis. However, the tight regulationmechanisms of IKKβ are still not clear. Here,we reported
that nemo-like kinase (NLK) is a suppressor of tumor necrosis factor (TNFα)-induced NF-κB signaling by
inhibiting the phosphorylation of IKKβ. Overexpression of NLK largely blocked TNFα-induced NF-κB activation,
p65 nuclear localization and IκBα degradation; whereas genetic inactivation of NLK showed opposing results.
Mechanistically, we identiﬁed that NLK interacted with IκB kinase (IKK)-associated complex, which in turn
inhibited the assembly of the TAK1/IKKβ and thereby, diminished the IκB kinase phosphorylation. Our results in-
dicate that NLK functions as a pivotal negative regulator in TNFα-induced activation of NF-κB via disrupting the
interaction of TAK1 with IKKβ.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Nuclear factor kappa-light-chain-enhancer of activated B cells (NF-
κB) is a family of transcription factor complexes that regulate cell
survival and proliferation. Dysregulation of NF-κB leads to chronic in-
ﬂammatory diseases and development of cancer [1,2]. In the resting
cells, NF-κB is sequestered in the cytoplasm by binding to members of
the IκB family of inhibitor proteins, which mask its nuclear localization
signal (NLS) [3,4]. NF-κB consisting of p50 and p65 is sequestered in the
cytoplasm by binding to IκB, an inhibitor of the nuclear localization sig-
nal. Upon various cytokine stimulations, the phosphorylated IκB protein
is degraded by the ubiquitin–proteasome pathway [5,6]. Degradation of
IκB results in release and nuclear translocation of NF-κB, thereby acti-
vating the NF-κB target gene transcription [7–9].
TNFα is one of themajor cytokines that activates theNF-κB signaling
pathway. Binding of TNFα to its receptor leads to assembly of the NF-κB
initial complex, which comprises TRADD, TRAF2/5 and RIP1 [10–12].
Notably, TRAF2 results in K63-linked polyubiquitination of RIP1,
which then recruits TAK1 and TAB2 to phosphorylate the IκB kinaseangxd@whu.edu.cn[13]. The activated IκB kinase subsequently phosphorylates IκB and pro-
motes IκB degradation, thereby activating NF-κB [14].
The IκB kinase complex consists of two catalytic subunits IKKα/IKKβ
and a regulatory subunit NEMO [15]. It is believed to play a central role
in the regulation of NF-κB signaling [16,17]. IKKα/IKKβdouble knockout
ﬁbroblasts fail to respond to various NF-κB activators [18]. Activation of
the IκB kinase complex is strictly controlled by the TGF-β-activated ki-
nase 1 (TAK1), which phosphorylates IKKβ at the two serine residues
within its activation loop [19,20]. However, how the IKKβ activity is
negatively regulated under the basal conditions remains unclear.
Nemo-like kinase (NLK), amember of theMAPK family, suppresses a
wide range of transcription factors including NF-κB [21]. Nevertheless,
the molecular mechanism by which NLK suppresses NF-κB transcrip-
tional activity remains elusive. Here, we report that NLK competes
with TAK1 to bind with IKKβ, leading to inhibition of the IKKβ phos-
phorylation and activation of the NF-κB signaling.
2. Materials and methods
2.1. Reagents and Constructs
Recombinant TNFα (R&D systems), NLK (Bethyl), Flag, HA, Myc,
GAPDH (CWBIO), IκBα, IKKα, IKKβ, p-IKKα/β, TAK1, p-TAK1, p65 (Cell
Signaling), and H3 (Epitomics) were purchased from the indicated com-
panies. The encoding 192 kinase clones were obtained from Addgene.
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mammalian expression plasmids were gifts from Hongbing Shu. TNF-
R1, p65, NLK and its mutants were constructed by molecular cloning
process.
2.2. Transfection and reporter assays
HEK293 cells (1 × 105) were seeded in 24-well plates and trans-
fected using TurboFect (Thermo). The indicated reporter plasmid and
pRL-TK were added to each transfection. After 24 h later, the dual-
speciﬁc luciferase assay kit (Promega) was used for the reporter assays.
2.3. Coimmunoprecipitation and immunoblot analysis
The HEK293 cells (1 × 106) were transfected and harvested in 400 μl
NP40 lysis buffer (30mMTris–HCl pH 7.4, 150mMNaCl, 1% NP40)with
proteinase cocktail inhibitors (Roche). The supernatant was incubated
with the indicated antibodies and Protein G beads (Roche) at 4 °C for
5 h. The beads werewashed three timeswith lysis buffer and fractionat-
ed by SDS/PAGE, which was then analyzed by western blotting.
2.4. RNA sequencing and data analysis
Total RNA was extracted and reverse transcribed. Then, the cDNA
was analyzed by Sinogenomax Co. The raw reads containing low-
quality data were cleaned by removing those contain either a base of
N or over half qualities below 20. Then, the resulting clean reads were
mapped to the human mRNA sequences with TopHat software. The
RPKM value, which is the normalized number of reads of each mRNA,
was calculated and used as the expression level. Genes expressed differ-
ently between every two samples were analyzed by the DESeq R pack-
age using a cutoff of P, 0.01.
2.5. RNA isolation and real-time PCR
Cells were lysed in TRIZOL (TAKARA), and RNAwas isolated accord-
ing to standard protocol. Then, total RNAwas used for reverse transcrip-
tion according to the manufacturer's manual (Fermentas). The amount
of mRNA was assayed by quantitative PCR. GAPDH: 5′-GAGTCAACGG
ATTTGGTCGT (forward) and 5′-GACAAGCTTCCCGTTCTCAG (reverse),
B94: 5′-TCTCACTGTTGACCCT TTGGC (forward) and TGACCCG CAGAAC
TGGAAG (reverse), cIAP2: 5′-TCAA GTTCAAGCCAGTTACC (forward)
and 5′-GACTCTGCATTTTCATCTCC (reverse), IL-6: 5′-TTCTCCACAAGC
GCCTTCGGTC (forward) and 5′-TCTG TGTGGGGCGGCTACATCT (re-
verse), ICAM1: 5′-TCAGTGTGACCGCAGAG GACGA (forward) and 5′-
TTGGGCGCCGGAAAGCTGTAGAT (reverse), TNFα: 5′-GCCGCATCGCCG
TCTCCTAC (forward) and 5′-CCTCAGCCCCCTCTGG GGTC (reverse),
IκBα: 5′-CGGGCTGAAGAAGGAGCGGC (forward) and 5′-ACGAGTCCCC
GTCCTCGGTG (reverse), NFκB1: 5′-TGGTATCAGACGCCAT CTA (for-
ward) and 5′-GCTGTCCTGTCCATTCTTAC (reverse), SOD2: 5′-GCACG
CTTACTACCTTCAGT (forward) and 5′-CTCCCAGTTGATTACATTCC
(reverse).
2.6. Cell fractionation
The cells were fractionated with NE-PER Nuclear and Cytoplasmic
Extraction Kit (Thermo) following instructions of the manufacturer.
2.7. Fluorescent confocal microscopy
The HeLa cells and HCT116 cells were cultured on coverslips and
transfected with cherry-NLK by TurboFect (Thermo). About 24 h later,
the cells were treated with or without TNFα for 30 min and ﬁxed with
4% paraformaldehyde for 10 min. Then, the ﬁxed cells were incubated
with the indicated antibody and observed using a confocal microscope
under a ×100 oil objective.2.8. Genetic knockout in human somatic cells
The genetic inactivation of NLK in human colorectal cancer cells
HCT116 was performed following a previously described method [22,
23]. Shortly, HEK293 cells were transfectedwith a target vector contain-
ing two homologous arms and two packaging vectors, AAV-Helper and
AAV-RC. After 3 days, the cells were collected with a scratcher and sub-
jected to freeze–thaw in liquid nitrogen three times, then the superna-
tant was harvested as the rAAV stock. A total of 1 × 105 HCT116 cells
were infected with rAAV virus about 2 days and were split into 6 96-
well plates in order to obtain as many single clones as possible. After
2 weeks of selection in 0.5 mg/ml G418, the single clones were
screened by PCR, and positive clones were ampliﬁed. Then, the clones
were passaged into onewell of a 24-well plate, and GFP-Cre Adenovirus
was added into the well to cut the resistant gene. One allele disrupt
clone were screened by PCR using proper primers. The second allele
was then disrupted using the same method.
3. Results
3.1. Identiﬁcation of NLK as a negative regulator of TNFα-induced NF-κB
signaling
To identify potential kinases that negatively regulate NF-κB tran-
scriptional activity, we screened approximately 200 kinase expression
clones in HEK293 cells, using a NF-κB reporter assay. As shown in
Fig. 1A, NLK strongly down-regulated the luciferase activity of the NF-
κB reporter. Moreover, overexpression of NLK inhibited the TNFα-
triggered activation of NF-κB in a dose-dependent manner (Fig. 1B). In
addition, quantitative RT-PCR (qRT-PCR) analyses indicated that NLK
suppressed the transcription of TNFα-induced genes including TNFα,
IκBα and B94 at various time points (Fig. 1C). It is important to note
here that Yasuda et al. previously showed that the inhibition of NF-κB
activity by NLK was kinase-activity dependent, but their analysis was
performed in the rest of the cells without TNFα stimulation [24]. None-
theless, to address whether the kinase activity of NLK was required for
suppression of the NF-κB activity with TNFα stimulation in this regard,
we further expressed a NLK kinase-dead mutant (NLKK167M) [25] in the
reporter system. Unexpectedly, it appeared that suppression of NF-κB
activation by NLK is independent of its kinase activity, as the kinase-
dead mutant NLKK167M still inhibited the NF-κB reporter activity in ei-
ther HEK293 or HeLa cells (Figs. 1D and S1).
3.2. Genetic inactivation of NLK leads to increased expression of NF-κB
target genes
To facilitate dissection of the mechanisms by which NLK suppresses
NF-κB activity, we set out to knockout NLK in HCT116 colorectal cancer
cells. We chose HCT116 cells for two reasons: ﬁrstly, TNFα can activate
the NF-κB signaling pathway in HCT116 cells; and secondly, HCT116
cells are widely employed for gene-targeting using rAAV-mediated ho-
mologous recombination [22,26]. In this study, both alleles of exon 3 of
the NLK gene were targeted by two rounds of rAAV-mediated homolog
recombination (Fig. 2A). The targeted clonewas validated by both geno-
mic PCR and Western blot analyses (Fig. 2B and C). The different gene
expression was presented between the NLK−/− HCT116 cells and the
wild-type cells in Fig. 2D via the RNA-seq analysis. As expected, the
RNA-seq proﬁling analysis showed that expression levels of a set of
NF-κB downstream genes, including RelB, IL8, SDC4, TNFAIP3 and
NFKB1A, were elevated in the NLK−/− cells in comparison to the paren-
tal HCT116 cells (Fig. 2E). Luciferase reporter assay showed that the
activity of NF-κB was higher in the NLK−/− cells in comparison to the
parental HCT116 cells regardless of the TNFα stimulation (Fig. 3A). Con-
sistent with the notion that NLK negatively regulates NF-κB signaling in
a kinase-independentmanner, overexpression ofwild-typeNLK and the
NLKK167M mutant both suppressed the NF-κB reporter activity and
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Fig. 1.NLK suppresses TNFα-induced NF-κB activation and the transcription levels of downstream genes independent of kinase activation. (A) NLKwas identiﬁed as a candidate repressor
of TNFα-induced NF-κB activation. Partial human kinase clones (Addgene) (100 ng/ml) were co-transfected into HEK293 cells with a NF-κB reporter (50 ng). 24 h later, TNFα (20 ng/ml)
was added to the cells for 12 h and then analyzed by the luciferase reporter assay. Thenumbers G7, G9, G10,H1,H4, H5, H6, H7, andH10 represent the genes PIP5K3, NEK3, GRK6, PACSIN1,
STK33, SYK, ADRBK1, RPS6KL1, and PDXK, respectively. (B) Gradually increased NLK expression inhibits TNFα-triggered NF-κB signaling. The NF-κB reporter and different doses of the
Flag-NLK plasmid were co-transfected into HEK293 cells. 24 h later, TNFα (20 ng/ml) was added to the cells for 12 h and assayed by a luciferase kit. (C) NLK inhibits TNFα-induced
NF-κB downstream gene transcription of TNFα, B94 and IκBα. HEK293 cells were transfected with the F-NLK plasmid (200 ng). 24 h later, TNFα (20 ng/ml) was added to the cells at in-
dicated times before real-time PCR experiment. (D) The kinase inactivation mutant of NLK (K167M) could not rescue the inhibition of NLK to NF-κB activation. NF-κB reporter, Flag-NLK
and Flag-NLK (K167M) were co-transfected into HEK293 cells. 24 h later, the cells were exposed to TNFα (20 ng/ml) for 12 h prior to the luciferase assay.
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B94) in the NLK−/− cells (Figs. 3B–C and S2). Taken together, these data
demonstrate that NLK negatively regulates TNFα-inducedNF-κB signal-
ing cascades.
3.3. NLK regulates p65/RelA nuclear localization and IκBα degradation
It is well recognized that the nuclear translocation of p65 is a key
step to NF-κB activation. Having demonstrated that NLK negatively
regulates NF-κB target gene expression, we have determined changes
of the protein level in NF-κB pathway and phosphorylation of TAK1
in the presence of NLK or NLKKM after TNFα stimulation. As shown in
Fig. 3D, the protein level of p65 and phosphorylation of TAK1 have not
changed. Therefore we set out to determine whether NLK regulates
NF-κBnuclear translocation. To this end,we examined the p65/RelA cel-
lular localization upon TNFα treatment. The immunoﬂuorescent stain-
ing analysis displayed that transfection of NLK signiﬁcantly inhibited
p65 nuclear localization in TNFα-treated cells (Fig. 4A). Similarly,
TNFα facilitated p65 translocation into the nucleus in NLK−/− HCT116
cells (Fig. 4B). In parallel, we performed Western-blotting analyses
to determine the contents of p65 included in cytoplasmic and nuclear
extracts which were collected from NLK-overexpressing 293 cells and
NLK−/− HCT116 cells with or without TNFα treatment. Consistently,
similar results were observed in these cells upon the indicated treat-
ment (Fig. 4C and D). Taken together, these data indicate that NLK is in-
volved in the TNFα-caused p65 subcellular translocalization.
In addition, p65 is sequestered in the cytoplasm by binding IκB pro-
tein under non-stimulated conditions. Upon stimulationwith cytokines,
pathogens or other stress stimuli, the IκB protein is degraded andreleases p65 to translocate into the nucleus [27]. Therefore, based on
our above results showing that NLK inﬂuences the TNFα-induced p65
translocalization, we speculated that degradation of IκBα might be
also affected by NLK. Indeed, we observed that overexpression of NLK
repressed the degradation of IκBα in TNFα-treated cells (Fig. 4E); in
contrast, deﬁciency of NLK led to the opposite results (Fig. 4F). Put to-
gether, these data suggest that NLKmay affect NF-κB signaling through
interrupting the degradation of IκBα.
3.4. NLK interacts with the IKK complex
To further dissect the role of NLK in TNFα-induced activation of NF-
κB signaling, we co-expressed several NF-κB signaling proteins in
HEK293 cells in the presence or absence of NLK. We found that NLK
inhibited the activation of IKKβ as well as its upstream components
TNFR, TRAF2 and TAK1/TAB1. However, NLK did not repress p65-
induced NF-κB activation (Fig. 5A). We also found that expression
IKKβ but not p65 strongly accelerated NF-κB activation in NLK−/−
HCT116 cells than in its paternal cells (Fig. 5B). Also, we examined the
binding capacity of NLK to its different components, using a competitive
coimmunoprecipitation. The results showed that NLK interacted with
the IKK complex and TAK1/TAB1, but not with p65 (Figs. 5C and S3).
Moreover, an endogenous coimmunoprecipitation analysis revealed
that NLK strongly interacted with IKKβ, but TNFα stimulation reduced
the NLK–IKK complex formation (Fig. 5D). This suggests that NLK may
orchestrate NF-κB signaling at the IKK complex stage.
Because IKKβ is the main player in the canonical NF-κB pathway,
we map the regions in IKKβ that interact with NLK. A series of IKKβ-
deletion constructs were generated and co-expressed with Flag-
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ﬁciency of NLK potentiates TNFα-induced transcription of endogenous TNFα, B94, IκBα and SOD2 genes in HCT116 cells. NLK+/+ and NLK−/− cells were treated with or without TNFα
(20 ng/ml) at the indicated times before real-time PCR experiments. (D) The expression of p65 and phosphorylation of TAK1 in HEK293 cells. Cell lysates from different cells were analyzed
after TNFα treatment by immunoblot using indicated antibody. GAPDH was used as a loading control.
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Fig. 4.NLK affects p65 translocation to the nucleus and IκBα degradation following TNFα treatment. (A) and (C) The higher expression of NLK inhibited p65 translocation to the nucleus
upon the TNFα treatment. (A) The cherry-NLK was transfected into HeLa cells. After 24 h, the cells were treated with or without TNFα (20 ng/ml) for 30min before the cells were ﬁxed.
Then, immunoﬂuorescent staining was carried out using a p65 antibody and DAPI. (C) HEK293 cells were fractionated into cytoplasmic and nuclear fractions. Nuclear immunoblot was
performed and detected using the p65 antibody. H3 was used as the nuclear loading control. (B) and (D) Deﬁciency of NLK potentiates p65 translocation to the nucleus following the
TNFα treatment. (B) NLK−/− HCT116 cells were treated with or without TNFα (20 ng/ml) for 15 min before the cells were ﬁxed. Then, immunoﬂuorescent staining was carried out
using the p65 antibody and DAPI. (D) NLK−/− HCT116 cells were fractionated into cytoplasmic and nuclear fractions. Nuclear immunoblotting was performed and detected using the
p65 antibody. H3 was used as the nuclear loading control. (E) and (F) The NLK affects IκBα degradation following the TNFα treatment. HEK293 and NLK−/− HCT116 cells transfected
with Flag-NLKwere treatedwith or without TNFα at indicated times. Then the cells were lysed and subjected to immunoblotting using the IκBα antibody. The normalized ﬁgurewas pre-
sented in the right line. GAPDH or β-actin was used as loading controls.
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main were both essential for its interaction with NLK (Fig. 5E). This
was evidenced by the fact that the NLK/IKKβ complex potentially
disrupted the phosphorylation of IKKβ. The domain mapping analysis
further revealed that the C-terminal region of NLK was required for
such an interaction (Fig. 5F).
3.5. NLK disrupts the interaction between TAK1 and IKKβ
It has been demonstrated that NLK associates with TAK1 and as
a consequence, negatively regulates the Wnt/β-catenin pathway [28,
29]. In the TNFα-induced NF-κB signaling cascade, the TAK1-mediated
activation of downstream kinases (IKKα and IKKβ) is the centralevent that transmits the signal to activate p65 [30]. The data presented
above suggest that NLKmay be tightly associatedwith the IKK complex.
However, whether NLK can inﬂuence the assembly of TAK1/IKK com-
plex remains unclear. To this end, we co-transfected Flag-tagged IKKβ
and HA-tagged TAK1 into HEK293 cells, together with either Myc-
tagged NLK or NLKmutants. Co-IP results exhibited that overexpression
of NLK signiﬁcantly attenuated assembly of TAK1/IKKβ (Fig. 6A). We
next determined whether deﬁciency of NLK enhanced the recruitment
of TAK1 to IKKβ, and found that loss of NLK promoted the TNFα-
induced association of TAK1with IKKβ (Fig. 6B). In similar experiments,
we observed that NLK also attenuated assembly of TAK1/IKKα (Fig. S4).
In addition, we found that NLK did not affect the interaction of NEMO
with IKKα/IKKβ (Fig. S5).
Fig. 5.NLK associates with IKK complex. (A) and (B) NLK inhibits TNFα-induced NF-κB activation at IKKβ level. (A) HEK293 cells were transfected with the indicated plasmids. Then the
cells were lysed and subjected to luciferase assays. (B) NLK+/+ and NLK−/− HCT116 cells were transfected with NF-κB reporter plasmid (50 ng) and the indicated plasmids. 24 h after
transfection, the cells were lysed before luciferase experiments were performed. (C) NLK interaction with IKKα, IKKβ, IKKγ. The HEK293 cells were transfected with HA-IKKα, HA-
IKKβ, HA-IKKγ (NEMO) and Flag-NLK. 24 h later, the cells were lysed and spun down. The supernatants were subjected to coimmunoprecipitation and subsequently immunoblotted
with the indicated antibodies. (D) Endogenous interaction between NLK and IKKβ. HEK293 cells (3 × 107) were treated with or without TNFα (20 ng/ml) for 60 min. The supernatants
were subjected to coimmunoprecipitation and subsequently immunoblotted with the indicated antibodies. (E) Interaction of IKKβmutants and NLK. HEK293 cells were transfected
with NLK and various IKKβ mutants. 24 h later, the cells were lysed and spun down. The supernatants were subjected to coimmunoprecipitation and subsequently immunoblotted
with the indicated antibodies. (F) NLK mutants interacted with IKKβ. The identical experiments were performed as in panel E.
1370 S.-Z. Li et al. / Biochimica et Biophysica Acta 1843 (2014) 1365–1372To conﬁrm the regulation of NLK-mediated regulation of NF-κB
signaling through disrupting the IKK complex, we further analyzed
the phosphorylation of IKKα and IKKβ in NLK- and its mutant-
overexpressing cells. Consistently, markedly decreased IKKα and IKKβ
phosphorylation was observed in the presence of either NLK or NLK
mutants (Fig. 6C). Collectively, these data indicate that NLK negatively
regulates TNFα-induced NF-κB activation through disrupting theTAK1/IKK complex (Fig. 6D), which consequently impairs the IKK phos-
phorylation and its downstream signal cascades.
4. Discussion
The NF-κB pathway, strictly controlled by the IKK complex, is crucial
to cell survival, proliferation, inﬂammation and immune regulation. In
Fig. 6.NLK affects the interaction between TAK1 and IKKβ and IκB kinase phosphorylation. (A) and (B) NLK affected the assembly of TAK1 and IKKβ. (A)Myc-NLK, Flag-IKKβ andHA-TAK1
were transfected into HEK293 cells. Cell extracts were immunoprecipitated with anti-Flag-beads and immunoblotted with the indicated antibody. (B) NLK+/+ and NLK−/− HCT116 cells
(5 × 107) were treatedwith orwithout TNFα (20 ng/ml) for 30min. Cell extracts were immunoprecipitated with TAK1 antibody or IgG and protein G followed by immuno-blotting with
the indicated antibody. (C) NLK inhibits the phosphorylation of IKKα and IKKβ. HEK293 cells were transfectedwith IKKα, IKKβwith orwithoutMyc-NLK andMyc-NLKKM. Then the phos-
phorylation levels of IKKα and IKKβwere detected by immunoblots. GAPDH was used as the loading control.
1371S.-Z. Li et al. / Biochimica et Biophysica Acta 1843 (2014) 1365–1372particular, negative regulation of the NF-κB pathway is well appreciated
to avoid cellular damage induced by over-activation of inﬂammatory cy-
tokines. In the present study, we identiﬁed NLK as a newnegative regula-
tor in the TNFα-induced NF-κB activation.
We observed that overexpression of NLK inhibited TNFα-induced
activation of NF-κB and its downstream gene expression. Conversely,
knockdown of endogenous NLK expression enhanced the transcription-
al activity of NF-κB in response to TNFα. The luciferase reporter analysis
further indicated that restoration of NLK in NLK−/− HCT116 cells
attenuated the TNFα-triggered activation of NF-κB. Moreover, the RNA
sequencing analysis revealed that a set of NF-κB target genes were
dys-regulated in NLK−/− HCT116 cells, compared with wild-type
HCT116 cells. Collectively, these results provide ﬁrst evidence that
NLK is a suppressor of the NF-κB pathway.
IKKβ is responsible for IκBα phosphorylation and subsequent degra-
dation, which causes p65 translocation to the nucleus [31]. Our results
presented in this study indicate that overexpression of NLK retards
the degradation of IκBα, and inhibits p65 translocation to the nucleus
in response to TNFα stimulation. In addition, we provide evidence
showing that NLK physically interacts with the IKK complex. The inter-
action between NLK and the IKK complex affected phosphorylation ofthe IKK complex by TAK1. However, how does NLK disrupt the TAK1–
IKK complex formation is not very clear. Previously, it has been reported
that TAK1 phosphorylates IKKβ and thereby transmits its signals [19].
We have known that NLK binds to the N-terminal region of IKKβ, but
whether owing to binding of the IKKβ N-terminal region led to reduc-
tion of TAK1 bind to IKK complex is unknown. In other words, TAK1
may bind this region. On the other hand, IKKβ is likely to impact the
TAK1/NLK complex by the IKK binding region of NLK. This needs further
more experiments to prove it. In the present study, we showed that NLK
was involved in the regulation of the TAK1–IKKβ signaling pathway
through interfering with the assembly of the TAK1/IKK complexes rath-
er than the NEMO/IKK complexes.
Our data suggest that NLK negatively regulates TAK1-mediated IKKβ
phosphorylation by competingwith TAK1 to bind to IKKβ. Interestingly,
in the absence of TNFα, deﬁciency of NLK promoted NF-κB activation,
compared with wild-type cells. This implicates that the activation of
NF-κB is tightly controlled by NLK under physiological conditions. How-
ever, although NLK is profoundly involved in NF-κB signaling, the NLK
mRNA levelswere not altered inNF-κB-activated cells (Fig. S6). Perhaps,
TNFα-mediated modiﬁcation of TAK1 may alter the phosphorylation
levels of NLK, which may affect the binding afﬁnity between NLK and
1372 S.-Z. Li et al. / Biochimica et Biophysica Acta 1843 (2014) 1365–1372IKKβ. In addition, the NLK activity and cellular localization under phys-
iological conditions also need to detect and more studies are necessary
to further clarify this question.
In summary, we report here that NLK contributes to maintenance of
cellular homeostasis in response to inﬂammation. NLK balances the ele-
vated phosphorylation of IκB kinases, which acts like a brake to avoid
NF-κB over-activation that leads to the aberrant inﬂammatory response.
Given that both TAK1 and IKK complexes are involved in IL-1β- and
virus-mediated signaling, the activation of NLK not only regulates the
TNFα-induced NF-κB activation, but also likewise participates in IL-
1β- and virus-mediated signaling. In this context, the kinase activation
of NLK is not necessary for the TNFα-induced NF-κB activation regula-
tion. However, we demonstrate that NLK regulates NF-κB activation
by interferingwith IKKα and β phosphorylation. Nevertheless, ourﬁnd-
ings may provide a new perspective to insight into the roles of NLK in
TNFα-mediated inﬂammatory processes.
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